drugset / Trial / NCT04449185
Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia
NaSingle-groupOpen-labelTreatment
Summary
The aims of the investigators' study are to investigate the effect of H.pylori eradication on the human gut microbiome and symptoms of functional dyspepsia.
Timeline
- Start
- 2020-06-30
- Primary completion
- 2021-10-30
- Completion
- 2021-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1000 mg | — |
| Subject | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Tegoprazan | Other / unclassified | 50 mg | — |